Asker Healthcare Group AB (OSTO:ASKER) Other Current Receivables: kr572 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ASKER Asker Healthcare Group AB OSTO:ASKER
13 GF Score
Price kr85.50
! 2 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB Other Current Receivables?

Asker Healthcare Group AB OSTO:ASKER +1.91% 13 Other Current Receivables is kr572 Mil as of Mar. 2026. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

Asker Healthcare Group AB's Other Current Receivables for the quarter that ended in Mar. 2026 was kr572 Mil.

Asker Healthcare Group AB's quarterly Other Current Receivables declined from Sep. 2025 (kr596.00 Mil) to Dec. 2025 (kr265.00 Mil) but then increased from Dec. 2025 (kr265.00 Mil) to Mar. 2026 (kr572.00 Mil).

Asker Healthcare Group AB's annual Other Current Receivables declined from Dec. 2023 (kr251.00 Mil) to Dec. 2024 (kr243.00 Mil) but then increased from Dec. 2024 (kr243.00 Mil) to Dec. 2025 (kr265.00 Mil).

Asker Healthcare Group AB Other Current Receivables Related Terms

Asker Healthcare Group AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB Other Current Receivables Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Current Receivables
256.00 251.00 243.00 265.00

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 475.00 525.00 596.00 265.00 572.00
OSTO:ASKER
13GF Score
Asker Healthcare Group AB OSTO:ASKER
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of kr572 Mil mean?
Asker Healthcare Group AB (OSTO:ASKER) has a Other Current Receivables of kr572 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Asker Healthcare Group AB and its competitors.
Is Asker Healthcare Group AB's Other Current Receivables too high?
Asker Healthcare Group AB's current Other Current Receivables is kr572 Mil. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Other Current Receivables compare to MCK and CAH?
Asker Healthcare Group AB's Other Current Receivables of kr572 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Distribution company?
A good Other Current Receivables depends on the Medical Distribution industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Asker Healthcare Group AB and its competitors. Asker Healthcare Group AB's current Other Current Receivables is kr572 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current Other Current Receivables of kr572 Mil. The current Other Current Receivables is kr572 Mil. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current Other Current Receivables is kr572 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKERs:UKI88:Germany
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score

Get the complete analysis for OSTO:ASKER

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr85.50
Price